October 9, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Torrid Holdings Inc. (“Torrid” or “the Company”) (NYSE: CURV). Investors who purchased Torrid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Torrid has violated… read more
October 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OpenSea NFTs. Investors who purchased OpenSea NFTs are encouraged to obtain additional information and assist the investigation. The investigation concerns whether OpenSea has violated federal securities laws. Investigation Details On August… read more
October 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nomura Holdings Inc ADR (“Nomura” or “the Company”) (NYSE: NMR). Investors who purchased Nomura securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nomura has… read more
September 30, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. (“Travere” or “the Company”) (NASDAQ: TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Travere has violated… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings Inc. (“Fortrea” or “the Company”) (NASDAQ: FTRE). Investors who purchased Fortrea securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fortrea has violated… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Medpace has violated… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stitch Fix, Inc. (“Stitch Fix” or “the Company”) (NASDAQ: SFIX). Investors who purchased Stitch Fix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Stitch… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SAP SE (“SAP” or “the Company”) (NYSE: SAP). Investors who purchased SAP securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether SAP has violated federal… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Light & Wonder, Inc. (“Light & Wonder” or “the Company”) (NASDAQ: LNW). Investors who purchased Light & Wonder securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 2seventy bio, Inc. (“2seventy bio” or “the Company”) (NASDAQ: TSVT). Investors who purchased 2seventy bio securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether 2seventy… read more
September 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Winnebago Industries, Inc. (“Winnebago” or “the Company”) (NYSE: WGO). Investors who purchased Winnebago securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Winnebago has violated… read more
September 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TEST COMPANY (“test” or “the Company”) (NASDAQ: TEST). Investors who purchased test securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether test has violated federal… read more
September 19, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. (“Progyny” or “the Company”) (NASDAQ: PGNY). Investors who purchased Progyny securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Progyny has violated federal… read more
September 18, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gogoro Inc. (“Gogoro” or “the Company”) (NASDAQ: GGR). Investors who purchased Gogoro securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gogoro has violated federal… read more
September 16, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Adobe Inc. (“Adobe” or “the Company”) (NASDAQ: ADBE). Investors who purchased Adobe securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Adobe has violated federal… read more
September 13, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Caleres, Inc. (“Caleres” or “the Company”) (NYSE: CAL). Investors who purchased Caleres securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Caleres has violated federal… read more
September 12, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aviat Networks, Inc. (“Aviat” or “the Company”) (NASDAQ: AVNW). Investors who purchased Aviat securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Aviat has violated… read more
September 12, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulcrum Therapeutics, Inc. (“Fulcrum” or “the Company”) (NASDAQ: FULC). Investors who purchased Fulcrum securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fulcrum has violated… read more
September 9, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mineralys Therapeutics, Inc. (“Mineralys” or “the Company”) (NASDAQ: MLYS). Investors who purchased Mineralys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Mineralys has violated… read more
September 9, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Napco Security Technologies, Inc. (“Napco” or “the Company”) (NASDAQ: NSSC). Investors who purchased Napco securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Napco has… read more
September 5, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of C3.ai, Inc. (“C3.ai” or “the Company”) (NYSE: AI). Investors who purchased C3.ai securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether C3.ai has violated federal… read more
September 4, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dyne Therapeutics, Inc. (“Dyne” or “the Company”) (NASDAQ: DYN). Investors who purchased Dyne securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dyne has violated… read more
August 30, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dollar General Corporation (“Dollar General” or “the Company”) (NYSE: DG). Investors who purchased Dollar General securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dollar… read more
August 28, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lions Gate Entertainment Corporation (“Lionsgate” or “the Company”) (NYSE: LGF.A; LGF.B). Investors who purchased Lionsgate securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lionsgate… read more
August 28, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lions Gate Entertainment Corporation (“Lionsgate” or “the Company”) (NYSE: LGF.A; LGF.B). Investors who purchased Lionsgate securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lionsgate… read more
August 28, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bank Of Montreal (“BoM” or “the Company”) (NYSE: BMO). Investors who purchased BoM securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BoM has violated… read more
August 27, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MaxLinear, Inc (“MaxLinear” or “the Company”) (NYSE: MXL). Investors who purchased MaxLinear securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MaxLinear has violated federal… read more
August 27, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Endeavour Silver Corporation (“Endeavour” or “the Company”) (NYSE: EXK). Investors who purchased Endeavour securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Endeavour has violated… read more
August 27, 2024 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for… read more
August 27, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sandbridge Acquisition Corporation (“Sandbridge”), which merged with Owlet, Inc. (“Owlet”) (NYSE: OWLT) on July 15, 2021. Investors who purchased Sandbridge shares prior to June 1, 2021, and continue to hold Owlet… read more